![David M. DeMedio](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Career history of David M. DeMedio
Former positions of David M. DeMedio
Companies | Position | Start | End |
---|---|---|---|
CANTALOUPE, INC. | Director of Finance/CFO | 1999-02-28 | 2015-08-30 |
Corporate Officer/Principal | 2015-08-30 | 2015-10-13 | |
Gammacan International, Inc.
![]() Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Director/Board Member | 2007-09-30 | 2008-09-16 |
Training of David M. DeMedio
Shippensburg University of Pennsylvania | Undergraduate Degree |
Statistics
International
United States | 3 |
Israel | 2 |
Operational
Director of Finance/CFO | 1 |
Corporate Officer/Principal | 1 |
Director/Board Member | 1 |
Sectoral
Finance | 2 |
Health Technology | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
CANTALOUPE, INC. | Finance |
Private companies | 1 |
---|---|
Gammacan International, Inc.
![]() Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Health Technology |
- Stock Market
- Insiders
- David M. DeMedio
- Experience